Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their… byPallavi MadhirajuSeptember 10, 2023